CopyFind
Eptokind 50mg/2ml Injection
medicine 📍 IN

Eptokind 50mg/2ml Injection

10,64 ₹

Analogs of Eptokind 50mg/2ml Injection

Find cheaper analogs and generic equivalents for Eptokind 50mg/2ml Injection.

Ingredients

ਸਰਗਰਮ ਤੱਤ: Phenytoin


ਉਤਪਾਦ ਝਲਕ

About Eptokind

Eptokind is a medication containing the active ingredient Phenytoin, classified as Anti-seizure medication. Phenytoin, sold under the brand name Dilantin among others, is an anti-seizure medication. It is useful for the prevention of tonic–clonic seizures and focal seizures, but not absence seizures. The intravenous form, fosphenytoin, is used for status epilepticus that does not improve with benzodiazepines.

Key Benefits & Uses

  • Used for: 1 INDICATIONS AND USAGE Parenteral Phenytoin Sodium Injection is indicated for the treatment of generalized tonic-clonic status epilepticus, and.
  • Used for: Intravenous phenytoin can also be substituted, as short-term use, for oral phenytoin
  • Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Phenytoin, the active ingredient in Eptokind, belongs to the Anti-seizure medication class. 1 INDICATIONS AND USAGE Parenteral Phenytoin Sodium Injection is indicated for the treatment of generalized tonic-clonic status epilepticus, and prevention and treatment of seizures occurring during neurosurgery. Intravenous phenytoin can also be substituted, as short-term use, for oral phenytoin. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Eptokind. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Eptokind for extended periods without medical advice.

Find in Pharmacies

Compare local prices and distance for Eptokind 50mg/2ml Injection.

Visitor ratings

Help others by rating how useful this product page is.

No ratings yet — be the first.